Astrazeneca Pharma India Ltd vs Rajnish Wellness Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 13, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8350 as of 13 May 14:50 . The P/E Ratio of Astrazeneca Pharma India Ltd changed from 80.7 on March 2021 to 185.9 on March 2025 . This represents a CAGR of 18.16% over 5 yearsThe P/E Ratio of Rajnish Wellness Ltd changed from 53.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 7525 crore on March 2021 to ₹ 21515 crore on March 2025 . This represents a CAGR of 23.38% over 5 yearsThe Market Cap of Rajnish Wellness Ltd changed from ₹ 5.26 crore on March 2021 to ₹ 70.7 crore on March 2025 . This represents a CAGR of 68.15% over 5 years The revenue of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 618.18 crore as compare to the Sep '25 revenue of ₹ 565.26 crore. This represent the growth of 9.36% The revenue of Rajnish Wellness Ltd for the Dec '25 is ₹ 23.61 crore as compare to the Sep '25 revenue of ₹ 12.32 crore. This represent the growth of 91.64% The ebitda of Astrazeneca Pharma India Ltd for the Dec '25 is ₹ 51.44 crore as compare to the Sep '25 ebitda of ₹ 76.06 crore. This represent the decline of -32.37% The ebitda of Rajnish Wellness Ltd for the Dec '25 is ₹ -1 crore as compare to the Sep '25 ebitda of ₹ 0.09 crore. This represent the decline of -1211% The net profit of Astrazeneca Pharma India Ltd changed from ₹ -11.79 crore to ₹ 32.59 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Rajnish Wellness Ltd changed from ₹ 0.17 crore to ₹ -0.91 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of Rajnish Wellness Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Rajnish Wellness Ltd

Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of 'Rajnish Hot Deals Private Limited'.
Subsequently, the Company was converted into a Public Limited Company on February 01, 2018 and was renamed to 'Rajnish Wellness Limited' on February 09, 2018. The Company is currently engaged in the business of selling various products in the categories ranging from consumer durables to ayurvedic personal care products.
The Company's major focus area is sexual wellness, energy revitalization and personal care products.
Current product portfolio is concentratedon ayuvedic products. The Company has product portfolio that covers major products including ayurvedic medicines, personal care products, sexual wellness and energy revitalization items etc.

FAQs for the comparison of Astrazeneca Pharma India Ltd and Rajnish Wellness Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Rajnish Wellness Ltd?

Market cap of Astrazeneca Pharma India Ltd is 20,770 Cr while Market cap of Rajnish Wellness Ltd is 45 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Rajnish Wellness Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Rajnish Wellness Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Rajnish Wellness Ltd?

As of May 13, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8308.3. On the other hand, Rajnish Wellness Ltd stock price is INR ₹0.45.

How do dividend payouts of Astrazeneca Pharma India Ltd and Rajnish Wellness Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Rajnish Wellness Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.